Catheter Precision Inc VTAK

US Health Care

$0.25 ▼ -9.61% ($-0.03)

⬇️ Below Yest. Low 🔥 High Short Interest 🎈 Low Float 🗓️ Earnings Next Week

Open $0.28

Prev Close $0.28

Day Range $0.25 – $0.28

52W Range $0.23 – $4.31

Market Cap $995,492

Beta -1.09

EPS (TTM) $-13.16

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NYSE MKT LLC
Currency	USD
IPO Date	2018-09-27
Shares Out.	3,610,000
Website	ramed.com/ ↗
Phone	13026587581
Employees	17
Revenue	$432,000
Gross Profit	$390,000
Net Income	-$1.7M
Free Cash Flow	-$8.8M
Total Assets	$35.1M
Total Liabilities	$25.9M
Equity	$9.2M

About Catheter Precision Inc

Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.

Catheter Precision Inc is a publicly traded company under the ticker symbol VTAK on the NYSE MKT LLC, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.